Rep. Alexandria Ocasio-Cortez threw a curveball this week. She praised the Trump administration’s fresh push to reschedule marijuana from the strict Schedule I category. Yet she warned that real change demands justice for war on drugs victims left in the dust. Her words spotlight a growing tension in the cannabis fight.
The White House acted fast on April 23. Acting Attorney General Todd Blanche signed an order shifting FDA-approved marijuana products to Schedule III. This move admits cannabis has medical value and low abuse risk.
No more blanket Schedule I label for approved meds. Researchers can now study it easier without federal roadblocks. A key hearing kicks off June 29 to eye broader shifts. DEA will weigh if all marijuana follows suit.
States feel the ripple. Medical cannabis thrives in 42 states today. Recreational sales roll in 24 places. But federal rules clashed hard until now.
AOC Voices Support With a Big Caveat
Ocasio-Cortez spoke out Wednesday on Capitol Hill. She sat down with reporters during a brisk walk up the steps.
“I will always welcome a descheduling of marijuana from Schedule I,” she said. The New York Democrat backs the step forward. But she stressed a core flaw.
People who gained from drug war arrests stand to cash in big on legal weed. Families wrecked by convictions get nothing. “That is a fundamental difference,” she added.
Her view echoes years of advocacy. She co-sponsored the HOPE Act in 2021. That bill aimed to fund state expungement of old pot charges.
War on Drugs Hits Black Communities Hard
Marijuana arrests fueled mass lockups for decades. Black Americans face arrest 3.6 times more than whites for the same habit. Usage rates match across races, FBI data shows.
Over 8 million pot busts happened from 2001 to 2010. Most were simple possession. Minorities bore the brunt in many spots.
Lives shattered. Jobs lost. Records block housing and loans. Equity means fixing this first, advocates say.
States like New York cleared thousands of records post-legalization. Federal action lags. Rescheduling helps research but skips past harms.
| Key War on Drugs Stats |
|---|
| Black arrest rate: 3.6x whites |
| Total pot arrests (2001-2010): 8M+ |
| Possession share: 88% |
Cannabis Boom Leaves Many Behind
Legal sales hit $29 billion last year. Projections top $47 billion by end of 2026. Big firms eye tax breaks from Schedule III.
Section 280E ends for medical ops. No more ban on business deductions. Banks may lend freer too.
Winners cluster in white-led startups. Few licenses go to ex-offenders. Social equity programs falter in places like California.
Ocasio-Cortez pushes holistic reform. Pair rescheduling with pardons and reinvestment. Half measures breed outrage, she hints.
Industry leaders cheer the shift. Stocks jumped on news. Patients gain research hope for pain and PTSD.
Path Ahead Blends Hope and Hurdles
Lawmakers eye full bills. Bipartisan talks heat up. Trump surprised skeptics with speed.
Rescheduling opens doors. Vets access vet-approved cannabis. Science fills knowledge gaps.
But true fix demands Congress act on equity. Expunge records. Fund community grants from sales tax.
Americans watch close. Pot touches daily life now. From medicine to markets, change brews fast.
This bold step from Trump sparks unlikely nods across aisles. AOC reminds us reform must heal old wounds too.
